Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Kai Li, Houhui Shi, Benxia Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 456

Showing 1-25 of 456 citing articles:

Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 315
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 271
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 173
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 144
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 117
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 91
STAT3 pathway in cancers: Past, present, and future
Hanqi Wang, Qi‐Wen Man, Fang‐Yi Huo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 90
Chronic inflammation, cancer development and immunotherapy
Yalei Wen, Ying‐Jie Zhu, Caishi Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 77
The Notch signaling pathway: a potential target for cancer immunotherapy
Xinxin Li, Xianchun Yan, Yufeng Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 64
Tumor-associated macrophages: an effective player of the tumor microenvironment
Udit Basak, Tania Sarkar, Sumon Mukherjee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 62
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 57
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Feyza Gül Özbay Kurt, Samantha Lasser, Ihor Arkhypov, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 50
A Microenvironment Dual‐Responsive Nano‐Drug Equipped with PD‐L1 Blocking Peptide Triggers Immunogenic Pyroptosis for Prostate Cancer Self‐Synergistic Immunotherapy
He Wang, Zhiyuan Gao, Di Jiao, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 16
Closed Access | Times Cited: 48
Cell membrane-coated nanomaterials for cancer therapy
Shiying Zeng, Qinglai Tang, Minna Xiao, et al.
Materials Today Bio (2023) Vol. 20, pp. 100633-100633
Open Access | Times Cited: 46
Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 45
Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis
Lina Wang, Lefan Zhu, Cong Liang, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1185-1200
Open Access | Times Cited: 43
Emerging biomaterials for tumor immunotherapy
Minna Xiao, Qinglai Tang, Shiying Zeng, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 39
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 35
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment
Damien Maggiorani, Oanh Lê, Véronique Lisi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
TME-Related Biomimetic Strategies Against Cancer
Cheng Peng, Yilin Xu, Jing Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 109-135
Open Access | Times Cited: 21
Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief
Mengying He, Mengyao Zhang, Tao Xu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 233-250
Closed Access | Times Cited: 15
Radiotherapy and immunology
Liangliang Wang, Connor Lynch, Sean P. Pitroda, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Open Access | Times Cited: 13
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics
Tosin Akinsipe, Rania Mohamedelhassan, Ayuba Akinpelu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top